143 related articles for article (PubMed ID: 19957041)
1. Prevention of local tumor recurrence following surgery using low-dose chemotherapeutic polymer films.
Liu R; Wolinsky JB; Walpole J; Southard E; Chirieac LR; Grinstaff MW; Colson YL
Ann Surg Oncol; 2010 Apr; 17(4):1203-13. PubMed ID: 19957041
[TBL] [Abstract][Full Text] [Related]
2. Prevention of local tumor growth with paclitaxel-loaded microspheres.
Azouz SM; Walpole J; Amirifeli S; Taylor KN; Grinstaff MW; Colson YL
J Thorac Cardiovasc Surg; 2008 May; 135(5):1014-21. PubMed ID: 18455578
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-eluting polymer film reduces locoregional recurrence and improves survival in a recurrent sarcoma model: a novel investigational therapy.
Liu R; Wolinsky JB; Catalano PJ; Chirieac LR; Wagner AJ; Grinstaff MW; Colson YL; Raut CP
Ann Surg Oncol; 2012 Jan; 19(1):199-206. PubMed ID: 21769471
[TBL] [Abstract][Full Text] [Related]
4. Enhanced efficacy of a novel controlled release paclitaxel formulation (PACLIMER delivery system) for local-regional therapy of lung cancer tumor nodules in mice.
Harper E; Dang W; Lapidus RG; Garver RI
Clin Cancer Res; 1999 Dec; 5(12):4242-8. PubMed ID: 10632366
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel-loaded expansile nanoparticles delay local recurrence in a heterotopic murine non-small cell lung cancer model.
Liu R; Khullar OV; Griset AP; Wade JE; Zubris KA; Grinstaff MW; Colson YL
Ann Thorac Surg; 2011 Apr; 91(4):1077-83; discussion 1083-4. PubMed ID: 21440127
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of hydrophilic Paclitaxel copolymer prodrug using locoregional delivery in human orthotopic non-small cell lung cancer xenograft models.
Zou Y; Fu H; Ghosh S; Farquhar D; Klostergaard J
Clin Cancer Res; 2004 Nov; 10(21):7382-91. PubMed ID: 15534115
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel tumor biodistribution and efficacy after intratumoral injection of a biodegradable extended release implant.
Shikanov A; Shikanov S; Vaisman B; Golenser J; Domb AJ
Int J Pharm; 2008 Jun; 358(1-2):114-20. PubMed ID: 18406086
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
Hainsworth JD; Greco FA
Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of poly(sebacic acid-co-ricinoleic acid) biodegradable delivery system for intratumoral delivery of paclitaxel.
Shikanov A; Vaisman B; Shikanov S; Domb AJ
J Biomed Mater Res A; 2010 Mar; 92(4):1283-91. PubMed ID: 19343769
[TBL] [Abstract][Full Text] [Related]
10. Cytoreductive surgery and intraoperative administration of paclitaxel-loaded expansile nanoparticles delay tumor recurrence in ovarian carcinoma.
Gilmore D; Schulz M; Liu R; Zubris KA; Padera RF; Catalano PJ; Grinstaff MW; Colson YL
Ann Surg Oncol; 2013 May; 20(5):1684-93. PubMed ID: 23128939
[TBL] [Abstract][Full Text] [Related]
11. Expansile nanoparticles: synthesis, characterization, and in vivo efficacy of an acid-responsive polymeric drug delivery system.
Griset AP; Walpole J; Liu R; Gaffey A; Colson YL; Grinstaff MW
J Am Chem Soc; 2009 Feb; 131(7):2469-71. PubMed ID: 19182897
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral delivery of paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres for Hep-2 laryngeal squamous cell carcinoma xenografts.
Xie M; Zhou L; Hu T; Yao M
Anticancer Drugs; 2007 Apr; 18(4):459-66. PubMed ID: 17351398
[TBL] [Abstract][Full Text] [Related]
13. A selective retinoid X receptor agonist bexarotene (Targretin) prevents and overcomes acquired paclitaxel (Taxol) resistance in human non-small cell lung cancer.
Yen WC; Corpuz MR; Prudente RY; Cooke TA; Bissonnette RP; Negro-Vilar A; Lamph WW
Clin Cancer Res; 2004 Dec; 10(24):8656-64. PubMed ID: 15623650
[TBL] [Abstract][Full Text] [Related]
14. Polymer chemotherapy for head and neck cancer.
Shikani AH; Domb AJ
Laryngoscope; 2000 Jun; 110(6):907-17. PubMed ID: 10852503
[TBL] [Abstract][Full Text] [Related]
15. The suppression of human prostate tumor growth in mice by the intratumoral injection of a slow-release polymeric paste formulation of paclitaxel.
Jackson JK; Gleave ME; Yago V; Beraldi E; Hunter WL; Burt HM
Cancer Res; 2000 Aug; 60(15):4146-51. PubMed ID: 10945622
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel-octreotide conjugates in tumor growth inhibition of A549 human non-small cell lung cancer xenografted into nude mice.
Shen H; Hu D; Du J; Wang X; Liu Y; Wang Y; Wei JM; Ma D; Wang P; Li L
Eur J Pharmacol; 2008 Dec; 601(1-3):23-9. PubMed ID: 18983839
[TBL] [Abstract][Full Text] [Related]
17. Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies.
Shalinsky DR; Brekken J; Zou H; Bloom LA; McDermott CD; Zook S; Varki NM; Appelt K
Clin Cancer Res; 1999 Jul; 5(7):1905-17. PubMed ID: 10430098
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor tyrosine kinase inhibitor does not improve paclitaxel effect in an orthotopic mouse model of lung cancer.
Onn A; Isobe T; Wu W; Itasaka S; Shintani T; Shibuya K; Kenji Y; O'reilly MS; Fidler IJ; Herbst RS
Clin Cancer Res; 2004 Dec; 10(24):8613-9. PubMed ID: 15623645
[TBL] [Abstract][Full Text] [Related]
19. Characterization of perivascular poly(lactic-co-glycolic acid) films containing paclitaxel.
Jackson JK; Smith J; Letchford K; Babiuk KA; Machan L; Signore P; Hunter WL; Wang K; Burt HM
Int J Pharm; 2004 Sep; 283(1-2):97-109. PubMed ID: 15363506
[TBL] [Abstract][Full Text] [Related]
20. Translymphatic chemotherapy by intrapleural placement of gelatin sponge containing biodegradable Paclitaxel colloids controls lymphatic metastasis in lung cancer.
Liu J; Meisner D; Kwong E; Wu XY; Johnston MR
Cancer Res; 2009 Feb; 69(3):1174-81. PubMed ID: 19176391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
